Hospital pharmacy and ophthalmological patients will benefit from the validation of two packages for eye drops

AIMPLAS in conjunction with ISS La Fe, MicroBios and PFP Termopolímeros has successfully completed the PHARMAPACKSAFE project. Thanks to this project, developed within the framework of the R&D national call Retos Colaboración and funded by the Spanish Ministry of Science, Innovation and Universities, it has been able to validate the inertia and stability of two plastic packages for eye drops that were discarded until now after a week.

The lack of information about the exact expiry date of the product in conditions of inertia and stability led hospital pharmacies to tell patients to have an appointment within seven days to get a new formulated drug. The research conducted in the project has verified that the packaging of three different eye drops (based on tacrolimus, chlorhexidine and voriconazole) in these packages is safe for six, four and six months stored at fridge, respectively.

From now on, this will allow reducing the number of tailored medications to be used as eye drops in hospital pharmacies with the subsequent cost saving as well as fewer appointments of patients to the hospital pharmacy.

AIMPLAS works on projects like these to improve people’s health within the framework of its commitment to the UN Sustainable Development Goals, in particular to Goal 3 on health and well-being.

The PHARMAPACKSAFE project, with file number RTC-2016-5215-1, is funded by ERDF/Ministry of Science, Innovation and Universities – State Research Agency, which aims to promote technological development, innovation and high-quality research.